aicep Portugal Global has acquired OPTIMOLD LIMITED for an undisclosed amount. The acquisition sees aicep Portugal Global take ownership of a UK-based manufacturer specializing in high precision injection moulded plastic components primarily for the medical equipment sector. This move signals a strategic expansion into advanced manufacturing capabilities.
OPTIMOLD LIMITED is renowned for its expertise in precision engineering, encompassing injection moulding, micro moulds, and multi-cavity moulding. The company produces critical components for medical equipment, devices, and drug delivery systems, serving areas such as medical diagnostics, surgery, and inhalation. Beyond medical applications, Optimold also provides molded polymer optics solutions and offers clean production environments for low to medium volume component manufacture, essential for pre-production testing and clinical trials. Its comprehensive services include mold design and manufacture, utilizing advanced machinery and processes such as 2 Material Injection Molding, automation, and turnkey solutions.
This acquisition is strategically significant, providing aicep Portugal Global with immediate access to advanced manufacturing technology and a specialized market niche within the high-growth medical device component industry. The integration of Optimold’s deep technical expertise and certified production processes is expected to create synergies that will enhance the combined entity's service offerings and market reach. Optimold’s focus on high precision, quality control, and clean production aligns with the increasing demands for reliable and sophisticated components in the healthcare sector.
The combined entity is anticipated to leverage Optimold’s specialized production capabilities and engineering talent to strengthen its position in the global market for medical and optical polymer components. This strategic integration is set to foster innovation and drive further development in high-precision manufacturing, catering to evolving industry needs.